Clinical trials have documented that taking LACTOGG®’s probiotic reduces the risk of infections in:
● Premature and young infants
● Toddlers and children attending nurseries and daycare centres
● Children with serious and repeated lung infections
● Children admitted to hospital
● Adults in intensive care units
● Elderly
It has positive effects on immunity by:
● Boosting immunisations
Taking LACTOGG®’s probiotic long term offers a way of reducing the risk of being infected.
Furthermore, the beneficial effects of this probiotic strain extend beyond just reducing infection risk. Even when we do become infected we can still make use of the GG probiotic’s positive effects on the immune system to help boost our ability to overcome the infection.
Less infections means less suffering and a lower financial burden for the patient and the family.
The less often we are infected the less we need to take antibiotics. On occasions where the doctor finds it necessary to prescribe antibiotics, taking LACTOGG®’s probiotic strain can also protect us from the side-effects of antibiotics.
How should LACTOGG® be taken?
Babies, children and adults:
At least 1 capsule or 1 sachet a day
Continue to take LACTOGG® even when infected and throughout the period(s) antibiotics are consumed.
References:
Khailova L. et al. Probiotic administration reduces mortality and improves intestinal epithelial homeostasis in experimental sepsis. Anaesthesiology 2013;119(1):166-177
Kumpu M et al. Recovery of probiotic Lactobacillus rhamnosus GG in tonsil tissue after oral administration: randomised, placebo-controlled,double-blind clinical trial. Br J Nutr 2013;109(12):2240-6
Lu R et al.Isolation, identification, and characterization of small bioactive peptides from Lactobacillus GG conditional media that exert both anti-Gram-negative and Gram-positive bactericidal activity.J Pediatr Gastroenterol Nutr 2009;49(1):23-30
Silva M et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother 1987;31(8):1231-1233
Wong S-S et al.Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Research Notes 2013;6:135
websiteusers@lactogg.com
Brochures
Privacy Policy
Glossary
